PSMA is a highly characterized prostate cancer biomarker localized to the prostate cancer cell membrane, suggesting its usefulness for in vivo prostate cancer specific targeting strategies [8], [9], [13]–[17]. This evidence concerns the gene FOLH1 and prostate cancer.